3-amino-3-cyclohexyl-propionic acid methyl ester | 757169-91-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3-amino-3-cyclohexyl-propionic acid methyl ester
• 英文别名: methyl (R,S)-3-amino-3-cyclohexylpropionate；Methyl 3-amino-3-cyclohexylpropanoate
• CAS: 757169-91-8
• 化学式: C₁₀H₁₉NO₂
• 分子量: 185.266
• InChiKey: QPIJOUZKOGIOFE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-amino-3-cyclohexyl-propionic acid methyl ester 、 丙二酸甲酯酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 methyl 3-cyclohexyl-3-[(3-methoxy-3-oxopropanoyl)amino]propanoate
  参考文献：
  名称：

  Design and structure–activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): Tetramic, tetronic acids and dihydropyridin-2-ones

  摘要：

  Based on a pharmacophore hypothesis substituted tetramic and tetronic acid 3-carboxamides as well as dihydropyridin-2-one- 3-carboxamides were investigated as inhibitors of undecaprenyl pyrophosphate synthase (UPPS) for use as novel antimicrobial agents. Synthesis and structure - activity relationship patterns for this class of compounds are discussed. Selectivity data and antibacterial activities for selected compounds are provided. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.02.009

文献信息

• Benzene compounds
  申请人：SUZUKI Nobuyasu

  公开号：US20070105899A1

  公开（公告）日：2007-05-10

  The present invention provides novel benzene compounds presented by the following formulas, and analogs thereof, that exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hypertension, arteriosclerosis), hypertension, and arteriosclerosis.

  本发明提供了以下公式所示的新型苯化合物及其类似物，具有ACC活性抑制作用，对肥胖、高脂血症、脂肪肝、高血糖、糖耐量受损、糖尿病、糖尿病并发症（糖尿病周围神经病变、糖尿病肾病、糖尿病视网膜病变和糖尿病大血管病变、高血压、动脉硬化）以及高血压和动脉硬化的治疗有效。
• [EN] NEW ANTIBACTERIAL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS ANTIBACTÉRIENS
  申请人：ACRAF

  公开号：WO2016096631A1

  公开（公告）日：2016-06-23

  The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.

  本发明涉及新型的抗菌化合物、含有它们的药物组合物以及它们作为抗菌剂的应用。
• Carboxylic Acid O–H Insertion Reaction of β-Ester Diazos Enabling Synthesis of β-Acyloxy Esters
  作者：Ziyi Li、Xinyu Yao、Xin Zhang、Haibo Mei、Jianlin Han

  DOI：10.1021/acs.joc.2c02023

  日期：2022.11.18

  β-ester diazos and their applications in carboxylic acid O–H insertion reactions have been reported, which afford β-acyloxy esters in excellent yield. Varieties of aryl- and alkyl-substituted diazos are well tolerated in this insertion reaction under mild and convenient conditions. Moreover, structural modification of the natural product and molecular drug can also be achieved in this reaction. This

  已经报道了非稳定化 β-酯重氮化合物的生成及其在羧酸 O-H 插入反应中的应用，从而以优异的收率提供 β-酰氧基酯。在温和方便的条件下，在此插入反应中可以很好地耐受各种芳基和烷基取代的重氮化合物。此外，该反应还可以实现天然产物和分子药物的结构修饰。该方案不仅实现了涉及不稳定β-酯重氮的反应，而且为合成β-酰氧基酯提供了一种有效的策略。
• Benzamides as ppar modulators
  申请人：Fernandez Serrat Anna

  公开号：US20060160894A1

  公开（公告）日：2006-07-20

  Compounds of general structure (I), wherein the central benzene ring may be substituted in the meta- or para-position; -A is an optionally substituted hydroxyl, alkoxyl, hydroxylamine, alkoxylamine or amine radical; -W is an N- and C-linked biradical selected from several possibilities; and -Z is a carbon radical selected from several possibilities. These compounds are PPARγ and PPARγ/PPARδ modulators and, therefore, are useful for the prophylactic and/or curative treatment of a condition or a disease mediated by these recetpcors.

  一般结构(I)的化合物，其中中心苯环可在元位或对位被取代；-A 是任选取代的羟基、烷氧基、羟胺、烷氧基胺或胺基；-W 是选自几种可能性的 N-和 C-连二自由基；-Z 是选自几种可能性的碳基。这些化合物是 PPARγ 和 PPARγ/PPARδ 调节剂，因此可用于预防和/或治疗由这些调节剂介导的病症或疾病。
• ANTIBACTERIAL COMPOUNDS
  申请人：AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A.

  公开号：US20170368017A1

  公开（公告）日：2017-12-28

  The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.